Article Details
Retrieved on: 2021-08-02 14:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Any regret that Roche might feel if lebri does prevail in phase 3 should be softened by potential milestones of over $1bn, plus royalties in the high single ...
Article found on: www.evaluate.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here